Page last updated: 2024-08-16

ro 31-8220 and mdv 3100

ro 31-8220 has been researched along with mdv 3100 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imada, K; Inokuchi, J; Kashiwagi, E; Naito, S; Shiota, M; Song, Y; Takeuchi, A; Tatsugami, K; Uchiumi, T; Yokomizo, A1

Other Studies

1 other study(ies) available for ro 31-8220 and mdv 3100

ArticleYear
Inhibition of protein kinase C/Twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Feb-15, Volume: 20, Issue:4

    Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Male; Nitriles; Nuclear Proteins; Phenylthiohydantoin; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Protein Kinase C; Protein Processing, Post-Translational; Receptors, Androgen; Signal Transduction; Twist-Related Protein 1

2014
chemdatabank.com